Free Newsletter
Measles death rate dips, but experts fear resurgence
Measles deaths declined 78 percent between 2000 and 2008 due to a global initiative to promote childhood vaccination. However, immunization experts warn of a resurgence in deaths if vaccination efforts are not sustained.
An estimated 164,000 people died from measles last year, compared with 733,000 in 2000. While measles deaths dropped almost 17 percent in the last year alone, health officials said there are signs that progress in fighting the disease is slowing, Bloomberg reports.
The Measles Initiative, a partnership that includes UNICEF and the American Red Cross, is taking the lead in the vaccination campaign. It warns of decreased political and financial commitment for the vaccination program and estimates that without more support, there could be 1.7 million measles-related deaths between 2010 and 2013, with more than half a million deaths in 2013 alone. They are particularly concerned about South-East Asia, where measles deaths declined only 46 percent between 2000 and 2008. The more modest declines are due primarily to delayed implementation of large-scale vaccination campaigns in India, the country with the majority of measles deaths, according to a recent statement.
"So much has been achieved in the past several years thanks to the hard work and commitment of national governments and donors. But with only two years until the target date, there are signs of stalling momentum," according to WHO Director-General Margaret Chan.
- read the statement from The Measles Initiative
- check out Bloomberg's coverage
Related Articles:
Researchers ready trials for inhalable measles vax
Wellcome Trust, Merck launch JV for affordable vaccines
Comments
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact



